Enter Note Done
Go to previous page in this tab
Event
  • Scientific Session
  • Bookmark Icon
  • Integrating Intestinal Biology into NAMs Across Sectors
  • Schedule
    Notes
  • Room 303‚ Convention Center
    Set Timezone


Chair: Maureen Bunger, Altis Biosystems Inc.
Co-Chair: Philip Demokritou, Rutgers School of Public Health

Primary Endorser: In Vitro and Alternative Methods Specialty Section


Endorser(s): Drug Discovery Toxicology Specialty Section


The gastrointestinal tract represents a highly dynamic and biologically complex interface that plays a central role in toxicological responses to dietary, pharmaceutical, and environmental exposures. As both a primary site of oral exposure and a secondary route for inhaled materials cleared through mucociliary transport and swallowing, the intestine integrates barrier function, transport processes, metabolism, immune signaling, and interactions with the microbiome. Despite its importance, intestinal biology remains underrepresented in many toxicological testing paradigms and integrated New Approach Methodologies (NAMs).

This session will provide the audience with a cross-sector perspective on how advances in human-relevant intestinal cell culture models are improving mechanistic understanding of exposure, uptake, transport, toxicity, and disease modulation. Through research examples spanning food and agricultural biotechnology, pharmaceutical development, and environmental toxicology, attendees will gain insight into how intestinal systems are being applied to evaluate biologically relevant endpoints including epithelial barrier integrity, inflammatory signaling, cellular uptake pathways, transport, and cross-talk of toxicants with intestinal diseases like Crohn’s Disease. Presentations will emphasize the importance of exposure context, including digestion, mucus interactions, absorption, and inflammatory state, when evaluating toxicological outcomes and will describe how model selection can be tailored to context of use, from screening to mechanistic investigation and translational interpretation.

The session aims to introduce a broad range of in vitro intestinal systems, including transwell cultures, organoids, gut-on-chip platforms, and integrated microphysiological systems (MPS), and highlight how these complementary models can be integrated to improve the predictive value and human relevance of toxicology strategies. Participants will also learn how these approaches are being incorporated into broader NAMs frameworks and weight-of-evidence strategies across industries and regulatory applications to support more transparent and context-relevant decision-making while reducing reliance on animal testing.

Session and Activity Type
Presentations